Enasidenib
Enasidenib is an orally available inhibitor of specific mutant forms of the mitochondrial enzyme isocitrate dehydrogenase type 2 (IDH2), with potential antineoplastic activity.

Catalog Number | T2346 |
Alternative Name(s) | AG-221 |
Research Area | Metabolism |
Molecular Formula | C19H17F6N7O |
CAS# | 1446502-11-9 |
SMILES | CC(C)(O)CNc1nc(Nc2ccnc(c2)C(F)(F)F)nc(n1)-c1cccc(n1)C(F)(F)F |
Size | 100 mg |
Supplier Page | https://www.targetmol.com/compound/Enasidenib |
Additional Information | https://www.targetmol.com/datasheet/T2346 |